Roundview Capital LLC Makes New Investment in Teleflex Incorporated (NYSE:TFX)

Roundview Capital LLC bought a new stake in shares of Teleflex Incorporated (NYSE:TFXFree Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 906 shares of the medical technology company’s stock, valued at approximately $226,000.

Several other institutional investors also recently bought and sold shares of the stock. Treasurer of the State of North Carolina lifted its holdings in shares of Teleflex by 0.9% in the 4th quarter. Treasurer of the State of North Carolina now owns 22,094 shares of the medical technology company’s stock worth $5,509,000 after acquiring an additional 202 shares during the last quarter. Allianz Asset Management GmbH increased its position in Teleflex by 38.6% during the 4th quarter. Allianz Asset Management GmbH now owns 8,503 shares of the medical technology company’s stock valued at $2,120,000 after purchasing an additional 2,370 shares during the period. Hsbc Holdings PLC grew its position in shares of Teleflex by 13.3% in the 4th quarter. Hsbc Holdings PLC now owns 83,474 shares of the medical technology company’s stock worth $20,795,000 after buying an additional 9,807 shares during the last quarter. Intech Investment Management LLC grew its position in shares of Teleflex by 33.6% in the 4th quarter. Intech Investment Management LLC now owns 3,474 shares of the medical technology company’s stock worth $866,000 after buying an additional 874 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its position in Teleflex by 9.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 12,397 shares of the medical technology company’s stock worth $3,091,000 after purchasing an additional 1,055 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. JMP Securities restated a “market outperform” rating and set a $285.00 price objective on shares of Teleflex in a research note on Friday, February 23rd. Truist Financial decreased their price objective on shares of Teleflex from $240.00 to $219.00 and set a “hold” rating for the company in a research note on Friday, May 3rd. Royal Bank of Canada decreased their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. Finally, StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and a consensus target price of $257.29.

View Our Latest Report on Teleflex

Insider Buying and Selling at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the company’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares of the company’s stock, valued at $2,261,250. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.43% of the stock is currently owned by corporate insiders.

Teleflex Price Performance

NYSE TFX traded up $1.48 on Friday, hitting $208.12. The company had a trading volume of 7,576 shares, compared to its average volume of 332,356. The company has a market capitalization of $9.80 billion, a PE ratio of 33.17, a PEG ratio of 1.96 and a beta of 1.13. The company’s fifty day moving average price is $211.71 and its 200-day moving average price is $228.11. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.51 and a quick ratio of 1.41. Teleflex Incorporated has a 12-month low of $177.63 and a 12-month high of $262.97.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The firm had revenue of $737.80 million during the quarter, compared to analyst estimates of $726.85 million. During the same quarter in the prior year, the firm posted $3.09 earnings per share. Teleflex’s quarterly revenue was up 3.8% on a year-over-year basis. As a group, analysts predict that Teleflex Incorporated will post 13.75 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th will be given a $0.34 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.65%. Teleflex’s payout ratio is currently 21.83%.

Teleflex Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.